☰

Georgianna G. Gould, Ph.D. - Publications

Affiliations: 
Syracuse University, Syracuse, NY, United States 
Tree Info Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gould GG, Lalani K, Pham T, Sanchez A, Smolik CM, Daws LC. Organic Cation Transporter Blocker Decynium 22 and Substrates Metformin and Berberine Enhance Social Interaction Preference in Adult Male Mice, Perhaps by Modulating Corticosterone Release The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05659  0.305
2019 Gilman TL, Owens WA, George CM, Metzel L, Vitela M, Ferreira L, Bowman MA, Gould GG, Toney GM, Daws LC. Age- and sex-specific plasticity in dopamine transporter function revealed by food restriction and exercise in a rat activity-based anorexia paradigm. The Journal of Pharmacology and Experimental Therapeutics. PMID 31481515 DOI: 10.1124/Jpet.119.260794  0.625
2019 Witt NA, Lee B, Ghent K, Zhang WQ, Pehrson AL, Sanchez C, Gould GG. Vortioxetine reduces marble burying but only transiently enhances social interaction preference in adult male BTBR TItpr3/J mice. Acs Chemical Neuroscience. PMID 31468969 DOI: 10.1021/Acschemneuro.9B00386  0.461
2019 Minakova E, Lang J, Medel-Matus JS, Gould GG, Reynolds A, Shin D, Mazarati A, Sankar R. Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism. Plos One. 14: e0210389. PMID 30629642 DOI: 10.1371/Journal.Pone.0210389  0.322
2018 Garbarino VR, Santos TA, Nelson AR, Zhang WQ, Smolik CM, Javors MA, Daws LC, Gould GG. Prenatal Metformin Exposure or Organic Cation Transporter 3 Knock-Out Curbs Social Interaction Preference in Male Mice. Pharmacological Research. PMID 30423430 DOI: 10.1016/J.Phrs.2018.11.013  0.366
2018 Garbarino VR, Gilman TL, Daws LC, Gould GG. Extreme Enhancement or Depletion of Serotonin Transporter Function and Serotonin Availability in Autism Spectrum Disorder. Pharmacological Research. PMID 30009933 DOI: 10.1016/J.Phrs.2018.07.010  0.653
2018 Perchuk A, Bierbower SM, Canseco-Alba A, Mora Z, Tyrell L, Joshi N, Schanz N, Gould GG, Onaivi ES. Developmental and behavioral effects in neonatal and adult mice following prenatal activation of endocannabinoid receptors by capsaicin. Acta Pharmacologica Sinica. PMID 29991708 DOI: 10.1038/S41401-018-0073-Z  0.341
2018 Mayer FP, Schmid D, Owens WA, Gould GG, Apuschkin M, Kudlacek O, Salzer I, Boehm S, Chiba P, Williams PH, Wu HH, Gether U, Koek W, Daws LC, Sitte HH. An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29773909 DOI: 10.1038/S41386-018-0053-5  0.345
2017 Krause-Heuer AM, Fraser-Spears R, Dobrowolski JC, Ashford ME, Wyatt NA, Roberts MP, Gould GG, Cheah WC, Ng CKL, Bhadbhade M, Zhang B, Greguric I, Wheate NJ, Kumar N, Koek W, et al. Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22. European Journal of Medicinal Chemistry. 137: 476-487. PMID 28624702 DOI: 10.1016/J.Ejmech.2017.06.011  0.318
2016 Mitchell NC, Bowman MA, Gould GG, Koek W, Daws LC. Ontogeny of NET expression and antidepressant-like response to desipramine in wild-type and SERT mutant mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27831486 DOI: 10.1124/Jpet.116.237305  0.401
2016 Mitchell NC, Gould GG, Koek W, Daws LC. Ontogeny of SERT expression and antidepressant-like response to escitalopram in wild-type and SERT mutant mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27288483 DOI: 10.1124/Jpet.116.233338  0.404
2015 Zhang WQ, Smolik CM, Barba-Escobedo PA, Gamez M, Sanchez JJ, Javors MA, Daws LC, Gould GG. Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains. Neuropharmacology. 90: 1-8. PMID 25445490 DOI: 10.1016/J.Neuropharm.2014.10.024  0.43
2014 Connors KA, Valenti TW, Lawless K, Sackerman J, Onaivi ES, Brooks BW, Gould GG. Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments. Aquatic Toxicology (Amsterdam, Netherlands). 151: 105-13. PMID 24411165 DOI: 10.1016/J.Aquatox.2013.12.005  0.41
2014 Gould GG, Burke TF, Osorio MD, Smolik CM, Zhang WQ, Onaivi ES, Gu TT, DeSilva MN, Hensler JG. Enhanced novelty-induced corticosterone spike and upregulated serotonin 5-HT1A and cannabinoid CB1 receptors in adolescent BTBR mice. Psychoneuroendocrinology. 39: 158-69. PMID 24126181 DOI: 10.1016/J.Psyneuen.2013.09.003  0.365
2013 Mitchell NC, Gould GG, Smolik CM, Koek W, Daws LC. Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function. Frontiers in Pharmacology. 4: 131. PMID 24191152 DOI: 10.3389/Fphar.2013.00131  0.407
2013 Horton RE, Apple DM, Owens WA, Baganz NL, Cano S, Mitchell NC, Vitela M, Gould GG, Koek W, Daws LC. Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 10534-43. PMID 23785165 DOI: 10.1523/Jneurosci.5687-11.2013  0.478
2012 Gould GG, Seillier A, Weiss G, Giuffrida A, Burke TF, Hensler JG, Rock C, Tristan A, McMahon LR, Salazar A, O'Connor JC, Satsangi N, Satsangi RK, Gu TT, Treat K, et al. Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 38: 260-9. PMID 22542870 DOI: 10.1016/J.Pnpbp.2012.04.011  0.394
2012 Valenti TW, Gould GG, Berninger JP, Connors KA, Keele NB, Prosser KN, Brooks BW. Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows. Environmental Science & Technology. 46: 2427-35. PMID 22296170 DOI: 10.1021/Es204164B  0.383
2012 Barba-Escobedo PA, Gould GG. Visual social preferences of lone zebrafish in a novel environment: strain and anxiolytic effects. Genes, Brain, and Behavior. 11: 366-73. PMID 22288820 DOI: 10.1111/J.1601-183X.2012.00770.X  0.335
2011 Daws LC, Gould GG. Ontogeny and regulation of the serotonin transporter: providing insights into human disorders. Pharmacology & Therapeutics. 131: 61-79. PMID 21447358 DOI: 10.1016/J.Pharmthera.2011.03.013  0.473
2011 Lau BY, Mathur P, Gould GG, Guo S. Identification of a brain center whose activity discriminates a choice behavior in zebrafish. Proceedings of the National Academy of Sciences of the United States of America. 108: 2581-6. PMID 21262817 DOI: 10.1073/Pnas.1018275108  0.306
2011 Gould GG, Hensler JG, Burke TF, Benno RH, Onaivi ES, Daws LC. Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. Journal of Neurochemistry. 116: 291-303. PMID 21070242 DOI: 10.1111/J.1471-4159.2010.07104.X  0.468
2008 Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 320-31. PMID 17406647 DOI: 10.1038/Sj.Npp.1301410  0.3
2007 Gould GG, Brooks BW, Frazer A. [(3)H] citalopram binding to serotonin transporter sites in minnow brains. Basic & Clinical Pharmacology & Toxicology. 101: 203-10. PMID 17697042 DOI: 10.1111/J.1742-7843.2007.00100.X  0.389
2007 Price DA, Owens WA, Gould GG, Frazer A, Roberts JL, Daws LC, Giuffrida A. CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. Journal of Neurochemistry. 101: 389-96. PMID 17250681 DOI: 10.1111/J.1471-4159.2006.04383.X  0.343
2007 Gould GG, Javors MA, Frazer A. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain. Biological Psychiatry. 61: 210-5. PMID 16650830 DOI: 10.1016/J.Biopsych.2006.02.029  0.426
2006 Mehta AK, Gould GG, Gupta M, Carter LP, Gibson KM, Ticku MK. Succinate semialdehyde dehydrogenase deficiency does not down-regulate gamma-hydroxybutyric acid binding sites in the mouse brain. Molecular Genetics and Metabolism. 88: 86-9. PMID 16406647 DOI: 10.1016/J.Ymgme.2005.11.012  0.314
2006 Gould GG, Altamirano AV, Javors MA, Frazer A. A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biological Psychiatry. 59: 408-14. PMID 16140280 DOI: 10.1016/J.Biopsych.2005.07.011  0.384
2006 Rossi DV, Valdez M, Gould GG, Hensler JG. Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 393-406. PMID 16035959 DOI: 10.1017/S1461145705005754  0.352
2005 Daws LC, Montañez S, Owens WA, Gould GG, Frazer A, Toney GM, Gerhardt GA. Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry. Journal of Neuroscience Methods. 143: 49-62. PMID 15763136 DOI: 10.1016/J.Jneumeth.2004.09.011  0.43
2004 Benmansour S, Altamirano AV, Jones DJ, Sanchez TA, Gould GG, Pardon MC, Morilak DA, Frazer A. Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biological Psychiatry. 55: 313-6. PMID 14744474 DOI: 10.1016/S0006-3223(03)00676-0  0.384
2003 Montañez S, Daws LC, Gould GG, Frazer A. Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. Journal of Neurochemistry. 87: 861-7. PMID 14622117 DOI: 10.1046/J.1471-4159.2003.02032.X  0.464
2003 Gould GG, Pardon MC, Morilak DA, Frazer A. Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1633-41. PMID 12825093 DOI: 10.1038/Sj.Npp.1300236  0.318
2003 Montañez S, Owens WA, Gould GG, Murphy DL, Daws LC. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. Journal of Neurochemistry. 86: 210-9. PMID 12807440 DOI: 10.1046/J.1471-4159.2003.01836.X  0.436
2003 Galici R, Galli A, Jones DJ, Sanchez TA, Saunders C, Frazer A, Gould GG, Lin RZ, France CP. Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology. 77: 132-40. PMID 12624535 DOI: 10.1159/000068650  0.349
2002 Montañez S, Daws LC, Gould GG, Gerhardt GA, Frazer A. Differential in vivo clearance of serotonin in rat dorsal raphe nucleus and CA3 region. Brain Research. 955: 236-44. PMID 12419542 DOI: 10.1016/S0006-8993(02)03470-4  0.452
2001 Clarke WP, Berg KA, Gould G, Frazer A. Characterization of 5-HT(₁A,B) and 5-HT(â‚‚A,C) serotonin receptor binding. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit1.23. PMID 21959751 DOI: 10.1002/0471141755.Ph0123S12  0.439
2000 Daws LC, Gould GG, Teicher SD, Gerhardt GA, Frazer A. 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. Journal of Neurochemistry. 75: 2113-22. PMID 11032901 DOI: 10.1046/J.1471-4159.2000.0752113.X  0.448
1999 Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 10494-501. PMID 10575045 DOI: 10.1523/Jneurosci.19-23-10494.1999  0.444
Show low-probability matches.